Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026

Audio By Carbonatix

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Jan 2, 2026--

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2026 of $1.30 per share on the company’s common stock. The dividend is payable on March 10, 2026 to shareholders of record at the close of business on February 24, 2026. The ex-dividend date is February 24, 2026.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260102290212/en/

CONTACT: Media contact:

[email protected] contact:

[email protected]

KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH HEALTH PHARMACEUTICAL CLINICAL TRIALS

SOURCE: Johnson & Johnson

Copyright Business Wire 2026.

PUB: 01/02/2026 08:00 AM/DISC: 01/02/2026 08:00 AM

http://www.businesswire.com/news/home/20260102290212/en